Literature DB >> 24474951

What is hypercalcemia? The importance of fasting samples.

Fadi F Siyam1, David M Klachko1.   

Abstract

The differentiation between primary or tertiary (both hypercalcemic) and secondary (normocalcemic) hyperparathyroidism requires the identification of hypercalcemia. Calcium in the blood exists as bound, complexed and ionized fractions. Calcium sensors on parathyroid cells interact only with the ionized fraction (about 50% of the total calcium concentration). Many formulas using albumin, total protein or phosphate to correct or adjust total calcium to reflect the level of ionized calcium may be accurate only within a limited range. In addition, they can introduce errors based on inaccuracies in the measurement of these other metabolites. Clinical conditions, mainly those illnesses affecting acid-base balance, can alter the proportions of bound and free calcium. How and when the blood samples are drawn can alter the level of total calcium. Prolonged standing or prolonged venous stasis causes hemoconcentration, increasing the bound fraction. Preceding exercise can also affect blood calcium levels. Ingestion of calcium supplements or calcium-containing nutrients can cause transient elevations in blood calcium levels lasting several hours, leading to unnecessary further testing. Fasting total calcium levels may be sufficient for monitoring progress. However, for diagnostic purposes, fasting ionized calcium levels should be used. Therefore, for an isolated high total calcium level, we recommend obtaining a repeat fasting total and ionized calcium measurement before further investigations. Hypercalcemia may be diagnosed if there are persistent or frequent total or, preferably, ionized calcium levels >3 SD above the mean of the normal range or if there are progressively rising levels.

Entities:  

Keywords:  Formulas; Hypercalcemia; Ionized calcium; Parathyroid hormone; Total calcium

Year:  2013        PMID: 24474951      PMCID: PMC3901605          DOI: 10.1159/000355526

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  30 in total

1.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 2.  Effect of physical activity on calcium homeostasis and calciotropic hormones: a review.

Authors:  Laurent Maïmoun; Charles Sultan
Journal:  Calcif Tissue Int       Date:  2009-09-16       Impact factor: 4.333

3.  Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease.

Authors:  Paolo Ferrari; Richard Singer; Aanchal Agarwal; Anne Hurn; Mary A Townsend; Paul Chubb
Journal:  Nephrology (Carlton)       Date:  2009-06       Impact factor: 2.506

4.  The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism.

Authors:  Gregory S Y Ong; John P Walsh; Bronwyn G A Stuckey; Suzanne J Brown; Enrico Rossi; Jennifer L Ng; Hieu H Nguyen; G Neil Kent; Ee Mun Lim
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

5.  Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers.

Authors:  J R Talbot; P Guardo; S Seccia; L Gear; D R Lubary; G Saad; M L Roberts; E Fradinger; A Marino; J R Zanchetta
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

6.  The absorption of tricalcium phosphate and its acute metabolic effects.

Authors:  R Shires; G M Kessler
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

7.  Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill.

Authors:  Jennichjen Slomp; Peter H J van der Voort; Rik Th Gerritsen; Jan A M Berk; Andries J Bakker
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

8.  Circadian variation in ionized calcium and intact parathyroid hormone: evidence for sex differences in calcium homeostasis.

Authors:  M S Calvo; R Eastell; K P Offord; E J Bergstralh; M F Burritt
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

9.  Specific heparin preparations interfere with the simultaneous measurement of ionized magnesium and ionized calcium.

Authors:  M E Lyon; D Bremner; T Laha; S Malik; P J Henderson; M A Kenny
Journal:  Clin Biochem       Date:  1995-02       Impact factor: 3.281

10.  A calculation model for serum ionized calcium based on an equilibrium equation for complexation.

Authors:  Susumu Takano; Hiroshi Kaji; Fujio Hayashi; Kanae Higashiguchi; Sachie Joukei; Yoshiaki Kido; Juro Takahashi; Kayo Osawa
Journal:  Anal Chem Insights       Date:  2012-07-04
View more
  7 in total

1.  Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients.

Authors:  Yoshitsugu Obi; Danh V Nguyen; Elani Streja; Matthew B Rivara; Connie M Rhee; Wei Ling Lau; Yanjun Chen; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  J Bone Miner Res       Date:  2016-11-01       Impact factor: 6.741

2.  European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants.

Authors:  Michela Bottani; Giuseppe Banfi; Elena Guerra; Massimo Locatelli; Aasne K Aarsand; Abdurrahman Coşkun; Jorge Díaz-Garzón; Pilar Fernandez-Calle; Sverre Sandberg; Ferruccio Ceriotti; Elisabet González-Lao; Margarita Simon; Anna Carobene
Journal:  Ann Transl Med       Date:  2020-07

3.  A Retrospective Study of Serum Calcium Status in Tehran, Iran (105,128 Samples, from 2009-2018).

Authors:  Dariush D Farhud; Marjan Zarif-Yeganeh; Atefeh Mehrabi; Ali-Reza Afshari; Mohammad Bagher Rokni; Keyvan Majidi; Maryam Jalali; Ali Akbar Amir Zargar; Abdolfattah Sarafnejad; Hamid Reza Sadeghipour; Shaghayegh Zokaei; Farideh Khosravi; Mahmoud Jalali; Mohammad Khazeni
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

4.  Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients.

Authors:  Yoshitsugu Obi; Rajnish Mehrotra; Matthew B Rivara; Elani Streja; Connie M Rhee; Wei Ling Lau; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2016-04-05       Impact factor: 5.958

5.  Association of serum calcium and phosphorus with measures of left ventricular structure and function: The ARIC study.

Authors:  Kripa Poudel; Amil M Shah; Erin D Michos; Aaron R Folsom; Suma Konety; Pamela L Lutsey
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-01-21       Impact factor: 4.222

6.  Lower serum calcium is independently associated with CKD progression.

Authors:  Cynthia J Janmaat; Merel van Diepen; Alessandro Gasparini; Marie Evans; Abdul Rashid Qureshi; Johan Ärnlöv; Peter Barany; Carl-Gustaf Elinder; Joris I Rotmans; Marc Vervloet; Friedo W Dekker; Juan Jesus Carrero
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

7.  Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Yohei Doi; Tatsufumi Oka; Sachio Kajimoto; Keiichi Kubota; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Nobuhiro Hashimoto; Yusuke Sakaguchi; Isao Matsui; Yoshitaka Isaka
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.